Hyperlipoproteinemia
13
0
0
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.7%
1 terminated out of 13 trials
90.9%
+4.4% vs benchmark
38%
5 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (13)
Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Cholesterol Levels
A Study of LY3561774 in Participants With Mixed Dyslipidemia
Dietary Effects on Lipoproteins and Thrombogenic Activity
Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia
Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia
Lipid Research Clinics Population Studies
Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia
Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia
Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia
The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia
A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin
Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins